Development of a new G-CSF product based on biosimilarity assessment
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/21/7/1419/391581/mdp574.pdf
Reference29 articles.
1. Clinical practice guidelines for the use of colony-stimulating factors in cancer treatment: implications for oncology nurses;Kearney;Eur J Oncol Nurs,2008
2. Common acute oncological emergencies: diagnosis, investigation and management;Walji;Postgrad Med J,2008
3. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells;Souza;Science,1986
4. Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor;Nagata;Nature,1986
5. Effect of escalating doses of recombinant human granulocyte colony-stimulating factor (filgrastim) on circulating neutrophils in healthy subjects;Borleffs;Clin Ther,1998
Cited by 84 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Filgrastim biosimilar (EP2006): A review of 15 years’ post-approval evidence;Critical Reviews in Oncology/Hematology;2024-04
2. Cost-efficiency analysis of conversion to biosimilar filgrastim for supportive cancer care and resultant expanded access analysis to supportive care and early-stage HER2+ breast cancer treatment in Saudi Arabia: simulation study;Journal of Medical Economics;2023-03-14
3. A prospective study of filgrastim pharmacokinetics in morbidly obese patients compared with non‐obese controls;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2021-11-22
4. Commentary - A comprehensive safety understanding of granulocyte-colony stimulating factor biosimilars and Intended Copy Biologics in treating chemotherapy associated febrile neutropenia;Toxicology and Applied Pharmacology;2020-11
5. Biosimilarity Assessment of 2 Filgrastim Therapeutics in Healthy Volunteers;Clinical Pharmacology in Drug Development;2020-08-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3